Muscarinic receptor antagonists: effects on pulmonary function.
Muscarinic receptor antagonists: effects on pulmonary function.
复制标题
DOI：
10.1007/978-3-642-23274-9_14
复制
发表时间：
2012-01-01
影响因子：
--
通讯作者：
Fryer, Allison D
中科院分区：
文献类型：
--
作者：
Buels, Kalmia S;Fryer, Allison D
在健康的肺中，毒蕈碱受体控制平滑肌张力、粘液分泌、血管舒张和炎症。在慢性阻塞性肺病（COPD）和哮喘中，胆碱能机制导致支气管收缩和粘液分泌增加，从而限制气流。本章回顾了肺中乙酰胆碱的神经元和非神经元来源，以及M β、M β和M β毒蕈碱受体亚型在肺生理学中的表达和作用。它还讨论了支持和反对副交感神经在哮喘中的作用的证据，以及毒蕈碱受体拮抗剂在COPD和哮喘中的当前使用和治疗潜力。
In healthy lungs, muscarinic receptors control smooth muscle tone, mucus secretion, vasodilation, and inflammation. In chronic obstructive pulmonary disease (COPD) and asthma, cholinergic mechanisms contribute to increased bronchoconstriction and mucus secretion that limit airflow. This chapter reviews neuronal and nonneuronal sources of acetylcholine in the lung and the expression and role of M₁, M₂, and M₃ muscarinic receptor subtypes in lung physiology. It also discusses the evidence for and against the role of parasympathetic nerves in asthma, and the current use and therapeutic potential of muscarinic receptor antagonists in COPD and asthma.